Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Compare
Equity
Direct
Sector - Healthcare
NAV: ₹ 28.68 as on 27-05-2024

About the Fund

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 11 July, 2019. The fund is managed by Dhaval Shah. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has ₹694 Cr worth of assets under management (AUM) as on Apr 2024 and is less than category average.
  2. The fund has an expense ratio 1.
Fund Performance
zero opening, trading, fund transfer fee
699 people have invested ₹ 1.1Cr in Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth in the last three months

Overview

Expense ratio
Expense ratio
1.01%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹694 Cr
Inception Date
Inception Date
11 July, 2019
Min Lumpsum/SIP
Min Lumpsum/SIP
₹1000/₹100
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
30.7%

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Distribution as on (30-Apr-24)

  • Equity 95.3%

  • Debt & Cash 4.7%

Size breakup

Large cap
40.8%
Mid cap
33.9%
Small cap
20.6%
Sector Allocation

Apr'24

Mar'24

Feb'24

Health
97.4%
Financial Services
2.1%
Basic Materials
0.5%

Top Holdings of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth as on (30-Apr-24)

  • Equity

Equity Holdings27

Gainers & Losers Returns for the month of Apr

Top Growth Drivers
1M Return
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
7.2%

Monthly Changes Updates

All changes are between Feb'24 and Apr'24
Fund Performance
Apr'24
Mar'24
Feb'24
Fund Returns
-0.81%
-0.07%
4.81%
Nifty 500
2.46%
-0.47%
1.58%
  • This fund’s returns stands at -0.81% whereas the fund’s underlying benchmark Nifty 500 returns stands at 2.46% as on Apr'24
  • This fund underperformed Nifty 500 by 3.27% in Apr'24
AUM Change
Parameters
Apr'24
Mar'24
Feb'24
AUM
₹ 699.6 Cr
₹ 699.6 Cr
₹ 691.9 Cr
  • AUM of the fund stands at 699.6 Cr as of Apr'24
  • AUM has remained same between Apr'24 and Mar'24
Fund Portfolio Changes

INDmoney Rank

Powered by IND quant engine
IND ranking is not available for this fund.

Pros

Hold on while we find any good points for this fund.

Cons

3Y returns in the bottom 25% of the category

Fund Manager

Dhaval Shah
Dhaval Shah
Fund Manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth, since 11 July 2019

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 23.98% since inception which is more than its category average return of 20.88%
Fund Allocations

Fund Allocations

This fund has an allocation of 95.28% in Equity, 0% in Debt and 4.72% in Cash related instruments
AUM size ₹694 Cr

AUM size ₹694 Cr

This fund has AUM of ₹694 Cr which is less than its category average of ₹ 1663 Cr
Expense Ratio 1.01%

Expense Ratio 1.01%

This fund has an expense ratio of 1.01% which is less than its category average expense ratio of 1.45%

Frequently Asked Questions

The current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is ₹28.68 as on 27-May-2024.
Existing (Absolute + CAGR) as on 27-May-2024.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
1.09%
1.09%
6 Month Returns
19.8%
19.8%
1 Year Returns
55.78%
55.78%
3 Years Returns
51.59%
14.87%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.01% as on April 2024
₹694 Cr as on April 2024
Sun Pharmaceuticals Industries Ltd(14.84%), Cipla Ltd(7.83%), Torrent Pharmaceuticals Ltd(7.41%), Apollo Hospitals Enterprise Ltd(6.33%), Fortis Healthcare Ltd(4.59%) as on April 2024
Health(92.82%), Financial Services(2.01%), Basic Materials(0.45%) as on April 2024
The alpha ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
0.65
1.04
-
As on April 2024
The alpha for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
1
0.96
-
As on April 2024
The Beta for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
2.52
0.72
-
As on April 2024
The sharpe ratio for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
15.59
14.95
-
As on April 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.24 as on April 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.27 as on April 2024. It tells the consistency of the fund in generating superior risk-adjusted performance
Dhaval Shah is the fund manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
The Exit load of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is 1%